Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

During the Trading Day
8.05 -0.05 / -0.62%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.05 0.00 / 0.00%
Volume: 65.7K
Health Services
Medical/Nursing Services

Company Description

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories to provide genetic and molecular testing services. The company offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Hematopathology, Hereditary Cancer, Molecular Oncology and Pathology. It offers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Contact Information

NeoGenomics, Inc.
12701 Commonwealth Drive
Fort Myers Florida 33913
P:(239) 768-0600
Investor Relations:
(239) 325-2001



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Douglas M. Van OortExecutive Chairman & Chief Executive Officer
Robert J. ShovlinChief Operating Officer
George A. CardozaChief Financial Officer
Maher AlbitarChief Medical Officer
Steven A. RossChief Information Officer